CT and MRI of hepatocellular carcinoma: An update

Expert Review of Anticancer Therapy

Volumn 10, Issue 4, 2010, Pages 507-519

  Ayyappan, Anoop P ^a   Jhaveri, Kartik S ^b  

^a Paul L Foster School of Medicine   (United States)

^b WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

Cirrhosis; Computed tomography; Hepatocellular carcinoma; Imaging; Liver; Liver neoplasm; MRI

Indexed keywords

ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; GADOBENATE DIMEGLUMINE; GADOLINIUM; GADOXETIC ACID; MANGAFODIPIR;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER STAGING; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; DRUG EXCRETION; DRUG UPTAKE; HEPATITIS C; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIOFREQUENCY ABLATION; REVIEW;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77951212202     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.10.24     Document Type: Review

References (93)

1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132(7), 2557-2576 (2007). (Pubitemid 46890874)
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 55(2), 74-108 (2005).
3. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 340(10), 745-750 (1999). (Pubitemid 29114292)
4. Bruix J, Boix L, Sala M, Llovet JM. Focus on hepatocellular carcinoma. Cancer Cell 5(3), 215-219 (2004). (Pubitemid 38402113)
5. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J. Clin. 58(2), 71-96 (2008).
6. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 362(9399), 1907-1917 (2003). (Pubitemid 37518510)
7. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 14(6), 969-974 (1991).
8. Di Bisceglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM, Lotze MT. NIH Conference. Hepatocellular carcinoma. Ann. Intern. Med. 108(3), 390-401 (1988).
9. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin. Liver Dis. 25(2), 181-200 (2005). (Pubitemid 40781071)
10. Bolondi L, Sofia S, Siringo S et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost-effectiveness analysis. Gut 48(2), 251-259 (2001). (Pubitemid 32141852)
11. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 130(7), 417-422 (2004). (Pubitemid 39044345)
12. Bruix J, Sherman M. Practice Guidelines Committee, American Association for the Study of Liver Diseases: management of hepatocellular carcinoma. Hepatology 42(5), 1208-1236 (2005).
13. Takayama T, Makuuchi M, Hirohashi S et al. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 336(8724), 1150-1153 (1990). (Pubitemid 20362906)
14. Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum. Pathol. 22(2), 172-178 (1991).
15. Hayashi M, Matsui O, Ueda K, Kawamori Y, Gabata T, Kadoya M. Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. Radiology 225(1), 143-149 (2002).
16. Kitao A, Zen Y, Matsui O, Gabata T, Nakanuma Y. Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography - radiologic-pathologic correlation. Radiology 252(2), 605-614 (2009).
17. Cancer of the Liver Italian Program (CLIP) Investigators. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 31(4), 840-845 (2000).
18. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin. Liver Dis. 19(3), 329-338 (1999). (Pubitemid 29488775)
19. Hemming AW, Cattral MS, Reed AI, Van Der Werf WJ, Greig PD, Howard RJ. Liver transplantation for hepatocellular carcinoma. Ann. Surg. 233(5), 652-659 (2001).
20. Stevens WR, Johnson CD, Stephens DH, Batts KP. CT findings in hepatocellular carcinoma: correlation of tumor characteristics with causative factors, tumor size, and histologic tumor grade. Radiology 191(2), 531-537 (1994).
21. Baron RL, Oliver JH 3rd, Dodd GD 3rd, Nalesnik M, Holbert BL, Carr B. Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT. Radiology 199(2), 505-511 (1996). (Pubitemid 26122003)
22. Lee HM, Lu DS, Krasny RM, Busuttil R, Kadell B, Lucas J. Hepatic lesion characterization in cirrhosis: significance of arterial hypervascularity on dual-phase helical CT. AJR Am. J. Roentgenol. 169(1), 125-130 (1997). (Pubitemid 27289621)
23. Murakami T, Kim T, Takamura M et al. Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT. Radiology 218(3), 763-767 (2001). (Pubitemid 32172560)
24. Laghi A, Iannaccone R, Rossi P et al. Hepatocellular carcinoma: detection with triple-phase multi-detector row helical CT in patients with chronic hepatitis. Radiology 226(2), 543-549 (2003). (Pubitemid 36313447)
25. Monzawa S, Ichikawa T, Nakajima H, Kitanaka Y, Omata K, Araki T. Dynamic CT for detecting small hepatocellular carcinoma: usefulness of delayed phase imaging. AJR Am. J. Roentgenol. 188(1), 147-153 (2007). (Pubitemid 46012501)
26. Jang HJ, Lim JH, Lee SJ, Park CK, Park HS, Do YS. Hepatocellular carcinoma: are combined CT during arterial portography and CT hepatic arteriography in addition to triple-phase helical CT all necessary for preoperative evaluation? Radiology 215(2), 373-380 (2000).
27. Tajima T, Honda H, Taguchi K et al. Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation. AJR Am. J. Roentgenol. 178(4), 885-897 (2002). (Pubitemid 34250225)
28. Yoon SH, Lee JM, So YH et al. Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation. AJR Am. J. Roentgenol. 193(6), W482-W489 (2009).
29. Bolondi L, Gaiani S, Celli N et al. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 42(1), 27-34 (2005). (Pubitemid 40911308)
30. Kudo M. Atypical large well-differentiated hepatocellular carcinoma with benign nature: a new clinical entity. Intervirology 47(3-5), 227-237 (2004). (Pubitemid 39279462)
31. Koike Y, Nakagawa K, Shiratori Y et al. Factors affecting the prognosis of patients with hepatocellular carcinoma invading the portal vein: a retrospective analysis using 952 consecutive HCC patients. Hepatogastroenterology 50(54), 2035-2039 (2003). (Pubitemid 37467989)
32. Pirisi M, Avellini C, Fabris C et al. Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study. J. Cancer Res. Clin. Oncol. 124(7), 397-400 (1998). (Pubitemid 28366020)
33. Takizawa D, Kakizaki S, Sohara N et al. Hepatocellular carcinoma with portal vein tumor thrombosis: clinical characteristics, prognosis, and patient survival analysis. Dig. Dis. Sci. 52(11), 3290-3295 (2007). (Pubitemid 47512562)
34. Ogren M, Bergqvist D, Bjorck M, Acosta S, Eriksson H, Sternby NH. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J. Gastroenterol. 12 (13), 2115-2211 (2006).
35. Rossi S, Ghittoni G, Ravetta V et al. Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma. Eur. Radiol. 18(8), 1749-1756 (2008).
36. Tarantino L, Francica G, Sordelli I et al. Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy. Abdom. Imaging 31(5), 537-544 (2006). (Pubitemid 46360843)
37. Krinsky GA, Lee VS, Theise ND et al. Transplantation for hepatocellular carcinoma and cirrhosis: sensitivity of magnetic resonance imaging. Liver Transpl. 8(12), 1156-1164 (2002). (Pubitemid 35469878)
38. Noguchi Y, Murakami T, Kim T et al. Detection of hepatocellular carcinoma: comparison of dynamic MR imaging with dynamic double arterial phase helical CT. AJR Am. J. Roentgenol. 180(2), 455-460 (2003). (Pubitemid 36135031)
39. Burrel M, Llovet JM, Ayuso C et al. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology 38(4), 1034-1042 (2003). (Pubitemid 37221687)
40. Kimura T, Hirokawa Y, Murakami Y et al. Reproducibility of organ position using voluntary breath-hold method with spirometer for extracranial stereotactic radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 60(4), 1307-1313 (2004). (Pubitemid 39440818)
41. Hussain SM, Wielopolski PA, Martin DR. Abdominal magnetic resonance imaging at 3.0T: problem or a promise for the future? Top. Magn. Reson. Imaging 16(4), 325-335 (2005). (Pubitemid 44350380)
42. Earls JP, Theise ND, Weinreb JC et al. Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation. Radiology 201(1), 207-214 (1996).
43. Kelekis NL, Semelka RC, Worawattanakul S et al. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images. AJR Am. J. Roentgenol. 170(4), 1005-1013 (1998). (Pubitemid 28172890)
44. Krinsky GA, Lee VS. MR imaging of cirrhotic nodules. Abdom. Imaging 25(5), 471-482 (2000).
45. Kelekis NL, Semelka RC, Woosley JT. Malignant lesions of the liver with high signal intensity on T1-weighted MR images. J. Magn. Reson. Imaging 6(2), 291-294 (1996). (Pubitemid 126701457)
46. Mitchell DG, Palazzo J, Hann HW, Rifkin MD, Burk DL Jr, Rubin R. Hepatocellular tumors with high signal on T1-weighted MR images: chemical shift MR imaging and histologic correlation. J. Comput. Assist. Tomogr. 15(5), 762-769 (1991).
47. Stevens WR, Gulino SP, Batts KP, Stephens DH, Johnson CD. Mosaic pattern of hepatocellular carcinoma: histologic basis for a characteristic CT appearance. J. Comput. Assist. Tomogr. 20(3), 337-342 (1996). (Pubitemid 26142280)
48. van den Bos IC, Hussain SM, Dwarkasing RS et al. MR imaging of hepatocellular carcinoma: relationship between lesion size and imaging findings, including signal intensity and dynamic enhancement patterns. J. Magn. Reson. Imaging 26 (6), 1548-1555 (2007).
49. EbaraM, Ohto M, Watanabe Y et al. Diagnosis of small hepatocellular carcinoma: correlation of MR imaging and tumor histologic studies. Radiology 159(2), 371-377 (1986). (Pubitemid 16121598)
50. Onaya H, Itai Y. MR imaging of hepatocellular carcinoma. Magn. Reson. Imaging Clin. N. Am. 8(4), 757-768 (2000).
51. Grazioli L, Olivetti L, Fugazzola C et al. The pseudocapsule in hepatocellular carcinoma: correlation between dynamic MR imaging and pathology. Eur. Radiol. 9(1), 62-67 (1999).
52. Ng IO, Lai EC, Ng MM, Fan ST. Tumor encapsulation in hepatocellular carcinoma: a pathologic study of 189 cases. Cancer 70(1), 45-49 (1992).
53. Wakasa K, Sakurai M, Kuroda C et al. Effect of transcatheter arterial embolization on the boundary architecture of hepatocellular carcinoma. Cancer 65(4), 913-919 (1990). (Pubitemid 20063496)
54. Ishigami K, Yoshimitsu K, Nishihara Y et al. Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings. Radiology 250(2), 435-443 (2009).
55. Freeny PC, Grossholz M, Kaakaji K, Schmiedl UP. Significance of hyperattenuating and contrast-enhancing hepatic nodules detected in the cirrhotic liver during arterial phase helical CT in pre-liver transplant patients: radiologic- histopathologic correlation of explanted livers. Abdom. Imaging 28(3), 333-346 (2003). (Pubitemid 36676164)
56. Brancatelli G, Baron RL, Peterson MS, Marsh W. Helical CT screening for hepatocellular carcinoma in patients with cirrhosis: frequency and causes of false positive interpretation. AJR Am. J. Roentgenol. 180(4), 1007-1014 (2003). (Pubitemid 36363042)
57. Jeong YY, Mitchell DG, Kamishima T. Small (<20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications. AJR Am. J. Roentgenol. 178(6), 1327-1334 (2002). (Pubitemid 34547809)
58. Sheu JC, Sung JL, Chen DS et al. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 89(2), 259-266 (1985). (Pubitemid 15028580)
59. Willatt JM, Hussain HK, Adusumilli S, Marrero JA. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 247(2), 311-330 (2008).
60. Kim YK, Kwak HS, Kim CS, Chung GH, Han YM, Lee JM. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT. Radiology 238(2), 531-541 (2006). (Pubitemid 43134365)
61. Bhartia B, Ward J, Guthrie JA, Robinson PJ. Hepatocellular carcinoma in cirrhotic livers double-contrast thin-section MR imaging with pathologic correlation of explanted tissue. AJR Am. J. Roentgenol. 180(3), 577-584 (2003). (Pubitemid 36237194)
62. Lee JM, Kim IH, Kwak HS, Youk JH, Han YM, Kim CS. Detection of small hypervascular hepatocellular carcinomas in cirrhotic patients: comparison of superparamagnetic iron oxide-enhanced MR imaging with dual-phase spiral CT. Kor. J. Radiol. 4(1), 1-8 (2003).
63. Kim SH, Choi D, Kim SH et al. Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am. J. Roentgenol. 184(4), 1069-1076 (2005). (Pubitemid 43821878)
64. Tang Y, Yamashita Y, Arakawa A et al. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging. Am. J. Roentgenol. 172(6), 1547-1554 (1999). (Pubitemid 29242335)
65. Pauleit D, Textor J, Bachmann R et al. Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver. Radiology 222(1), 73-80 (2002). (Pubitemid 34031469)
66. Ward J, Guthrie JA, Scott DJ et al. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis. Radiology 216(1), 154-162 (2000). (Pubitemid 30434736)
67. Huppertz A, Haraida S, Kraus A et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT - initial observations. Radiology 234(2), 468-478 (2005). (Pubitemid 40139918)
68. Sahani DV, O'Malley ME, Bhat S, Hahn PF, Saini S. Contrast-enhanced MRI of the liver with mangafodipir trisodium: imaging technique and results. J. Comput. Assist. Tomogr. 26(2), 216-222 (2002). (Pubitemid 34233368)
69. Kim SH, Kim SH, Lee J et al. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am. J. Roentgenol. 192(6), 1675-1681 (2009).
70. Kim YK, Kim CS, Lee YH, Kwak HS, Lee JM. Comparison of superparamagnetic iron oxide-enhanced and gadobenate dimeglumine-enhanced dynamic MRI for detection of small hepatocellular carcinomas. AJR Am. J. Roentgenol. 182(5), 1217-1223 (2004) (Pubitemid 38525517)
71. But DY, Lai CL, Yuen MF. Natural history of hepatitis-related hepatocellular carcinoma. World J. Gastroenterol. 14 (11), 1652-1656 (2008). (Pubitemid 351493370)
72. Kaczynski J, Hansson G, Wallerstedt S. Metastases in cases with hepatocellular carcinoma in relation to clinicopathologic features of the tumor: an autopsy study from a low endemic area. Acta Oncol. 34(1), 43-48 (1995).
73. Lee YT, Geer DA. Primary liver cancer: pattern of metastasis. J. Surg. Oncol. 36(1), 26-31 (1987). (Pubitemid 17139540)
74. Catalano OA, Choy G, Zhu A, Hahn PF, Sahani DV. Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging. Radiology 254(1), 154-162 (2010).
75. Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AJR Am. J. Roentgenol. 170(2), 397-402 (1998). (Pubitemid 28083846)
76. Vandecaveye V, De Keyzer F, Verslype C et al. Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma. Eur. Radiol. 19(10), 2456-2466 (2009).
77. Naik M, Mannelli L, Chandarana H, Lee V, Taouli B. Hepatocellular carcinoma: assessment of tumor oxygenation with BOLD MRI. Proc. Intl Soc. Mag. Reson. Med. 16, 3741 (2008).
78. Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann. Surg. 232(3), 381-391 (2000).
79. Lim HK, Choi D, Lee WJ et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT. Radiology 221(2), 447-454 (2001). (Pubitemid 33043430)
80. Park Y, Choi D, Lim HK et al. Growth rate of new hepatocellular carcinoma after percutaneous radiofrequency ablation: evaluation with multiphase CT. AJR Am. J. Roentgenol. 191(1), 215-220 (2008). (Pubitemid 351955191)
81. Lencioni R, Cioni D, Crocetti L et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234(3), 961-967 (2005). (Pubitemid 40250844)
82. Harrison LE, Koneru B, Baramipour P et al. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma. J. Am. Coll. Surg. 197(5), 759-764 (2003). (Pubitemid 38199577)
83. Park MH, Rhim H, Kim YS, Choi D, Lim HK, Lee WJ. Spectrum of CT findings after radiofrequency ablation of hepatic tumors. Radiographics 28(2), 379-390 (2008).
84. Choi D, Lim HK, Kim SH et al. Assessment of therapeutic response in hepatocellular carcinoma treated with percutaneous radio frequency ablation: comparison of multiphase helical computed tomography and power Doppler ultrasonography with a microbubble contrast agent. J. Ultrasound Med. 21(4), 391-401 (2002). (Pubitemid 34259900)
85. Bruix J, Llovet JM, Castells A et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 27(6), 1578-1583 (1998). (Pubitemid 28264682)
86. Llovet JM, Real MI, Montana X et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 359(9319), 1734-1739 (2002). (Pubitemid 34607087)
87. Kubota K, Hisa N, Nishikawa T et al. Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of lipiodol CT, power Doppler sonography, and dynamic MRI. Abdom. Imaging 26(2), 184-190 (2001). (Pubitemid 32187124)
88. Morimoto M, Shirato K, Sugimori K et al. Contrast-enhanced harmonic gray-scale sonographic-histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. Am. J. Roentgenol. 181(1), 65-69 (2003). (Pubitemid 36741462)
89. Chen CY, Li CW, Kuo YT et al. Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants - initial experience. Radiology 239(2), 448-456 (2006).
90. Mannelli L, Kim S, Hajdu C et al. Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver. AJR Am. J. Roentgenol. 193(4), 1044-1052 (2009).
91. Choi SH, Lee JM, Yu NC et al. Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI. AJR Am. J. Roentgenol. 191(2), 529-536 (2008).
92. Rode A, Bancel B, Douek P et al. Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J. Comput. Assist. Tomogr. 25(3), 327-336 (2001). (Pubitemid 32440782)
93. Peterson MS, Baron RL, Marsh JW Jr, Oliver JH 3rd, Confer SR, Hunt LE. Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation. Radiology 217(3), 743-749 (2000).